Medlive Technology Co Ltd
HKEX:2192
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
5.98
9.88
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Medlive Technology Co Ltd stock under the Base Case scenario is 6.62 HKD. Compared to the current market price of 9.23 HKD, Medlive Technology Co Ltd is Overvalued by 28%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Medlive Technology Co Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Medlive Technology Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Medlive Technology Co Ltd
Balance Sheet Decomposition
Medlive Technology Co Ltd
Current Assets | 4B |
Cash & Short-Term Investments | 3.9B |
Receivables | 137m |
Other Current Assets | 40.5m |
Non-Current Assets | 900m |
Long-Term Investments | 606.4m |
PP&E | 19.5m |
Intangibles | 264.8m |
Other Non-Current Assets | 9.3m |
Current Liabilities | 150.2m |
Accounts Payable | 10.1m |
Other Current Liabilities | 140.1m |
Non-Current Liabilities | 111.2m |
Long-Term Debt | 8.9m |
Other Non-Current Liabilities | 102.3m |
Earnings Waterfall
Medlive Technology Co Ltd
Revenue
|
481.9m
CNY
|
Cost of Revenue
|
-188.5m
CNY
|
Gross Profit
|
293.4m
CNY
|
Operating Expenses
|
15.6m
CNY
|
Operating Income
|
309m
CNY
|
Other Expenses
|
-18.7m
CNY
|
Net Income
|
290.3m
CNY
|
Free Cash Flow Analysis
Medlive Technology Co Ltd
CNY | |
Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
Medlive Technology Co Ltd's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
Score
Medlive Technology Co Ltd's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Medlive Technology Co Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Score
Medlive Technology Co Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Medlive Technology Co Ltd
According to Wall Street analysts, the average 1-year price target for Medlive Technology Co Ltd is 11.01 HKD with a low forecast of 10.48 HKD and a high forecast of 11.76 HKD.
Dividends
Current shareholder yield for Medlive Technology Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Medlive Technology Co., Ltd. operates as an investment holding company. The company is headquartered in Beijing, Beijing. The company went IPO on 2021-07-15. The firm mainly operates three segments. Its Precision Marketing and Corporate Solutions segment provides precision marketing solutions and corporate solutions. Its precision marketing solutions include digital detailing, digital marketing consulting and digital content creation services. Its revenue of its corporate solutions is primarily software as a service (SaaS). The Medical Knowledge Solutions segment mainly provides professional medical information and medical software services. The Intelligent Patient Management Solutions segment mainly provides online patient consultation and prescription services and patient management services. The firm mainly conducts its business within domestic market.
Contact
IPO
Employees
Officers
The intrinsic value of one Medlive Technology Co Ltd stock under the Base Case scenario is 6.62 HKD.
Compared to the current market price of 9.23 HKD, Medlive Technology Co Ltd is Overvalued by 28%.